de Bruyn J H, Man in't Veld A J, Wenting G J, Derkx F H, Schalekamp M A
Eur J Clin Pharmacol. 1981;20(3):163-8. doi: 10.1007/BF00544593.
The effects of captopril 450 mg/day for 4 weeks on blood pressure, heart rate, cardiac output and extracellular fluid volume were compared in severe, often drug-resistant hypertension (n = 23), mild to moderate hypertension associated with renal artery stenosis (n = 10) and mild to moderate essential hypertension (n = 20). Plasma renin in the three groups was 52 +/- 19, 58 +/- 17 and 20 +/- 4 microU/ml (mean +/- SEM), respectively. Blood pressure fell by 18 +/- 4%, 21 +/- 2% and 18 +/- 1%. The pressure drop was mainly due to a fall in peripheral vascular resistance. Addition of the diuretic hydrochlorothiazide (25-100 mg/day) caused a further fall in resistance. Despite the vasodilator effect of captopril, reflex cardiostimulation and reactive fluid retention were not observed. In severe hypertension, captopril alone was more effective in lowering blood pressure than combined diuretic-betablocker-vasodilator therapy. Moreover, cardiac output in these patients was higher and resistance was lower after captopril than during combined treatment. Thus, captopril was capable of normalising the abnormal haemodynamic state in patients with essential hypertension, and in hypertension associated with renal artery stenosis. Despite marked differences in pre-treatment plasma renin, the effects of captopril on systemic haemodynamics were similar in all the patients.
比较了卡托普利450毫克/天连续服用4周对重度(通常耐药)高血压患者(n = 23)、与肾动脉狭窄相关的轻至中度高血压患者(n = 10)以及轻至中度原发性高血压患者(n = 20)的血压、心率、心输出量和细胞外液量的影响。三组患者的血浆肾素水平分别为52±19、58±17和20±4微单位/毫升(平均值±标准误)。血压分别下降了18±4%、21±2%和18±1%。血压下降主要归因于外周血管阻力的降低。加用利尿剂氢氯噻嗪(25 - 100毫克/天)导致阻力进一步下降。尽管卡托普利具有血管舒张作用,但未观察到反射性心脏刺激和反应性液体潴留。在重度高血压患者中,单用卡托普利降低血压比联合使用利尿剂 - β受体阻滞剂 - 血管舒张剂治疗更有效。此外,与联合治疗期间相比,这些患者服用卡托普利后的心输出量更高,阻力更低。因此,卡托普利能够使原发性高血压患者以及与肾动脉狭窄相关的高血压患者的异常血流动力学状态恢复正常。尽管治疗前血浆肾素水平存在显著差异,但卡托普利对所有患者全身血流动力学的影响相似。